200 related articles for article (PubMed ID: 22929054)
1. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance.
Abdel-Maksoud M; House B; Wasfy M; Abdel-Rahman B; Pimentel G; Roushdy G; Dueger E
Ann Clin Microbiol Antimicrob; 2012 Aug; 11():24. PubMed ID: 22929054
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
3. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].
Keşli R; Bilgin H; Yılmaz H
Mikrobiyol Bul; 2017 Jul; 51(3):260-268. PubMed ID: 28929962
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiological and microbiological study of brucellosis in Kuwait.
Dimitrov Ts; Panigrahi D; Emara M; Awni F; Passadilla R
Med Princ Pract; 2004; 13(4):215-9. PubMed ID: 15181327
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.
Torkaman Asadi F; Hashemi SH; Alikhani MY; Moghimbeigi A; Naseri Z
Jpn J Infect Dis; 2017 May; 70(3):235-238. PubMed ID: 27580575
[TBL] [Abstract][Full Text] [Related]
9. The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
Celik E; Kayman T; Buyuk F; Gulmez Saglam A; Abay S; Akar M; Karakaya E; Balkan Bozlak CE; Coskun MR; Buyuk E; Celebi O; Sahin M; Saticioglu IB; Durhan S; Baykal A; Ersoy Y; Otlu S; Aydin F
Microb Pathog; 2023 Sep; 182():106261. PubMed ID: 37488036
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp.
Ozhak-Baysan B; Ongut G; Ogunc D; Gunseren F; Sepin-Ozen N; Ozturk F; Aktepe OC; Gultekin M
Pol J Microbiol; 2010; 59(1):55-60. PubMed ID: 20568531
[TBL] [Abstract][Full Text] [Related]
12. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.
Gutiérrez Altés A; Díez Enciso M; Peña García P; Campos Bueno A
Antimicrob Agents Chemother; 1982 Mar; 21(3):501-3. PubMed ID: 6980624
[TBL] [Abstract][Full Text] [Related]
14. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.
Turkmani A; Ioannidis A; Christidou A; Psaroulaki A; Loukaides F; Tselentis Y
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():24. PubMed ID: 17014707
[TBL] [Abstract][Full Text] [Related]
16. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.
Parlak M; Güdücüoğlu H; Bayram Y; Çıkman A; Aypak C; Kılıç S; Berktaş M
Int J Med Sci; 2013; 10(10):1406-11. PubMed ID: 23983603
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Ilhan Z; Solmaz H; Ekin IH
J Vet Med Sci; 2013; 75(8):1035-40. PubMed ID: 23545462
[TBL] [Abstract][Full Text] [Related]
19. Identification of Brucella species isolated from proven brucellosis patients in Izmir, Turkey.
Köse S; Kiliç S; Ozbel Y
J Basic Microbiol; 2005; 45(4):323-7. PubMed ID: 16028204
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]